Vous utilisez un navigateur non pris en charge.
Certaines fonctionnalités de ce site peuvent ne pas fonctionner correctement. Pour une expérience utilisateur optimale, veuillez consulter ce site en utilisant Chrome, Firefox, Safari ou Edge.

Résistance aux antimicrobiens (RAM)

Informations sur les tests

Antimicrobial resistance (AMR) leads to longer hospital stays, increased mortality, and higher medical costs.

AMR is one of the top 10 global public health threats facing humanity, with misuse and overuse of antimicrobials being the main drivers in the development of drug-resistant pathogens. In addition to death and disability, prolonged illness results in longer hospital stays and financial challenges for those impacted.1

Why AMR Matters:

2,8 Million
infections annually1

35 000
deaths annually in the U.S.2

4,6 Billion
in extra healthcare costs3

Relationship to Healthcare-Associated Infections (HAIs)4,5

HAIs are frequently caused by drug-resistant bacteria. HAIs can:

1 in 3
bacteria associated with HAIs are resistant to antibiotics4

4,5 Million
annual number of patients with at least one HAI5

1 in 15
number of patients on any given day with at least one HAI4

Everyone is at Risk6

Some, however, are high-risk and disproportionally impacted:

Patients undergoing cancer therapy

Patients with weakened immune systems

Patients undergoing dialysis

Patients undergoing complex surgery

How We Can Build Better Antibiotic Stewardship with the GeneXpert® System

With on-demand molecular diagnostics, today’s healthcare providers are able to quickly identify whether an infection is present and if it is drug-resistant, in minutes, rather than days. Cepheid’s GeneXpert® system helps those on the frontlines of resistance prevent the inappropriate use of antimicrobials and preserve our antibiotic weapons―now and in the future. For more information, download our antimicrobial stewardship brochure.

 

Download AMR Infographic Brochure

Livres blancs et webinaires connexes

Connecté pour de meilleurs résultats

Demande d’information
1 Centers for Disease Control and Prevention: Antibiotic Resistance Threats in the United States, 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf.
Accessed 18 avril, 2022.
2 World Health Organization: Résistance aux antimicrobiens. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed 18 avril, 2022.
3 Centers for Disease Control and Prevention: CDC Study Shows National Healthcare Costs from AR Infections Exceed $4,6 Billion. https://www.cdc.gov/ncezid/what-we-do/partnership-in-
action/healthcare-costs-associated-with-ar-infections.html. Accessed 18 avril, 2022.
4 MedTech Europe. 2014. Healthcare-Associated Infections Brochure. Accessed Feb 2021. https://www.medtecheurope.org/resource-library/hai-brochure/
5 ECDC. 2018. Healthcare-Associated Infections - A Threat to Patient Safety in Europe. Accessed Feb 2021.
https://www.ecdc.europa.eu/en/publications-data/infographichealthcare-associated-infections-threat-patient-safety-europe
6 CDC. 2019. Antibiotic Resistance Threats in the United States 2019. Accessed Feb 2021. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf 
7 World Health Organization. “Antimicrobial resistance: global report on surveillance.” Juin 2014.
Retour en haut de page
Powered by Translations.com GlobalLink OneLink SoftwarePowered By OneLink